These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


239 related items for PubMed ID: 28084321

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Extracellular vesicle-associated soluble CD163 and CD206 in patients with acute and chronic inflammatory liver disease.
    Nielsen MC, Andersen MN, Grønbæk H, Damgaard Sandahl T, Møller HJ.
    Scand J Gastroenterol; 2020 May; 55(5):588-596. PubMed ID: 32393080
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Peripheral artery disease is associated with a high CD163/TWEAK plasma ratio.
    Moreno JA, Dejouvencel T, Labreuche J, Smadja DM, Dussiot M, Martin-Ventura JL, Egido J, Gaussem P, Emmerich J, Michel JB, Blanco-Colio LM, Meilhac O.
    Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1253-62. PubMed ID: 20299688
    [Abstract] [Full Text] [Related]

  • 7. Tumor necrosis factor α-converting enzyme (TACE/ADAM17) mediates ectodomain shedding of the scavenger receptor CD163.
    Etzerodt A, Maniecki MB, Møller K, Møller HJ, Moestrup SK.
    J Leukoc Biol; 2010 Dec; 88(6):1201-5. PubMed ID: 20807704
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Monocyte/macrophage-derived soluble CD163: a novel biomarker in multiple myeloma.
    Andersen MN, Abildgaard N, Maniecki MB, Møller HJ, Andersen NF.
    Eur J Haematol; 2014 Jul; 93(1):41-7. PubMed ID: 24612259
    [Abstract] [Full Text] [Related]

  • 11. Soluble CD163, a specific macrophage activation marker, is decreased by anti-TNF-α antibody treatment in active inflammatory bowel disease.
    Dige A, Støy S, Thomsen KL, Hvas CL, Agnholt J, Dahlerup JF, Møller HJ, Grønbaek H.
    Scand J Immunol; 2014 Dec; 80(6):417-23. PubMed ID: 25346048
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Association of CD163+ macrophages and local production of soluble CD163 with decreased lymphocyte activation in spondylarthropathy synovitis.
    Baeten D, Møller HJ, Delanghe J, Veys EM, Moestrup SK, De Keyser F.
    Arthritis Rheum; 2004 May; 50(5):1611-23. PubMed ID: 15146432
    [Abstract] [Full Text] [Related]

  • 14. Elevated Serum Levels of Soluble CD163 in Polymyositis and Dermatomyositis: Associated with Macrophage Infiltration in Muscle Tissue.
    Peng QL, Zhang YL, Shu XM, Yang HB, Zhang L, Chen F, Lu X, Wang GC.
    J Rheumatol; 2015 Jun; 42(6):979-87. PubMed ID: 25877505
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Regulation of CD163 mRNA and soluble CD163 protein in human adipose tissue in vitro.
    Fjeldborg K, Møller HJ, Richelsen B, Pedersen SB.
    J Mol Endocrinol; 2014 Oct; 53(2):227-35. PubMed ID: 25074267
    [Abstract] [Full Text] [Related]

  • 19. Plasma Soluble CD163 Level Independently Predicts All-Cause Mortality in HIV-1-Infected Individuals.
    Knudsen TB, Ertner G, Petersen J, Møller HJ, Moestrup SK, Eugen-Olsen J, Kronborg G, Benfield T.
    J Infect Dis; 2016 Oct 15; 214(8):1198-204. PubMed ID: 27354366
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.